{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:07:05Z","timestamp":1768410425196,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union \u2013 Next Generation EU","award":["PNRR-MCNT2-2023-12378342"],"award-info":[{"award-number":["PNRR-MCNT2-2023-12378342"]}]},{"DOI":"10.13039\/501100007065","name":"University of Salerno","doi-asserted-by":"crossref","award":["FARB 2021 - Study of the biological activity of extracellular BAG3 protein in the progression of post-infarction myocardial fibrosis"],"award-info":[{"award-number":["FARB 2021 - Study of the biological activity of extracellular BAG3 protein in the progression of post-infarction myocardial fibrosis"]}],"id":[{"id":"10.13039\/501100007065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Adolph Hutter professorship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Cardiovasc Health"],"DOI":"10.1038\/s44325-025-00092-4","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:00:52Z","timestamp":1761814852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BAG3 concentrations and heart failure events among individuals undergoing coronary and peripheral angiography"],"prefix":"10.1038","volume":"2","author":[{"given":"Margot","family":"De Marco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liberato","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Caterina","family":"Turco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Vecchione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"De Laurenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"92_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1074\/jbc.274.2.781","volume":"8","author":"S Takayama","year":"1999","unstructured":"Takayama, S., Xie, Z. & Reed, J. C. An evolutionarily conserved family of Hsp70\/Hsc70 molecular chaperone regulators. J. Biol. Chem. 8, 781\u2013786 (1999).","journal-title":"J. Biol. Chem."},{"key":"92_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jcp.21397","volume":"215","author":"S Franceschelli","year":"2008","unstructured":"Franceschelli, S. et al. Bag3 gene expression is regulated by heat shock factor 1. J. Cell Physiol. 215, 575\u2013577 (2008).","journal-title":"J. Cell Physiol."},{"key":"92_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.tips.2016.04.007","volume":"37","author":"C Behl","year":"2016","unstructured":"Behl, C. Breaking BAG: the co-chaperone BAG3 in health and disease. Trends Pharm. Sci. 37, 672\u2013688 (2016).","journal-title":"Trends Pharm. Sci."},{"key":"92_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semcdb.2017.08.049","volume":"78","author":"M De Marco","year":"2018","unstructured":"De Marco, M. Role of BAG3 in cancer progression: a therapeutic opportunity. Semin. Cell Dev. Biol. 78, 85\u201392 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"92_CR5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.trecan.2020.07.001","volume":"6","author":"M De Marco","year":"2020","unstructured":"De Marco, M., Turco, M. C. & Marzullo, L. BAG3 in tumor resistance to therapy. Trends Cancer 6, 985\u2013988 (2020).","journal-title":"Trends Cancer"},{"key":"92_CR6","doi-asserted-by":"publisher","first-page":"129628","DOI":"10.1016\/j.bbagen.2020.129628","volume":"8","author":"L Marzullo","year":"2020","unstructured":"Marzullo, L., Turco, M. C. & De Marco, M. The multiple activities of BAG3 protein: mechanisms. Biochim. Biophys. Acta Gen. Subj. 8, 129628 (2020).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"92_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149415","volume":"16","author":"JA Kirk","year":"2021","unstructured":"Kirk, J. A., Cheung, J. Y. & Feldman, A. M. Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease. J. Clin. Invest. 16, e149415 (2021).","journal-title":"J. Clin. Invest."},{"key":"92_CR8","doi-asserted-by":"crossref","unstructured":"Turco, M. C. BAG3 in the heart. JACC Basic Transl. Sci. 8, 840\u2212842 (2023).","DOI":"10.1016\/j.jacbts.2023.02.012"},{"key":"92_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2353\/ajpath.2006.060250","volume":"6","author":"S Homma","year":"2006","unstructured":"Homma, S. et al. BAG3 deficiency results in fulminant myopathy and early lethality. Am. J. Pathol. 6, 761\u2013773 (2006).","journal-title":"Am. J. Pathol."},{"key":"92_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23272-z","volume":"1","author":"TG Martin","year":"2021","unstructured":"Martin, T. G. et al. Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover. Nat. Commun. 1, 2942 (2021).","journal-title":"Nat. Commun."},{"key":"92_CR11","first-page":"820","volume":"7","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Bag3 regulates mitochondrial function and the inflammasome through canonical and non-canonical pathways in the heart. J. Am. Coll. Cardiol. Basic Trans. Sci. 7, 820\u2013839 (2023).","journal-title":"J. Am. Coll. Cardiol. Basic Trans. Sci."},{"key":"92_CR12","doi-asserted-by":"publisher","first-page":"H1124","DOI":"10.1152\/ajpheart.00736.2023","volume":"5","author":"TG Martin","year":"2024","unstructured":"Martin, T. G., Sherer, L. A. & Kirk, J. A. BAG3 localizes to mitochondria in cardiac fibroblasts and regulates mitophagy. Am. J. Physiol. Heart Circ. Physiol. 5, H1124\u2013H1130 (2024).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"92_CR13","doi-asserted-by":"publisher","first-page":"11308","DOI":"10.3390\/ijms252011308","volume":"20","author":"HQ Qu","year":"2024","unstructured":"Qu, H. Q., Wang, J. F., Rosa-Campos, A., Hakonarson, H. & Feldman, A. M. The role of BAG3 protein interactions in cardiomyopathies. Int. J. Mol. Sci. 20, 11308 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"92_CR14","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/humu.21603","volume":"32","author":"T Arimura","year":"2011","unstructured":"Arimura, T., Ishikawa, T., Nunoda, S., Kawai, S. & Kimura, A. Dilated cardiomyopathy-associated BAG3 mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes. Hum. Mutat. 32, 1481\u20131491 (2011).","journal-title":"Hum. Mutat."},{"key":"92_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ajhg.2011.01.016","volume":"88","author":"N Norton","year":"2011","unstructured":"Norton, N. et al. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am. J. Hum. Genet. 88, 273\u2013282 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"92_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","volume":"32","author":"E Villard","year":"2011","unstructured":"Villard, E. et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur. Heart J. 32, 1065\u20131076 (2011).","journal-title":"Eur. Heart J."},{"key":"92_CR17","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","volume":"72","author":"F Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez, F. et al. Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations. J. Am. Coll. Cardiol. 72, 2471\u20132481 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"92_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacbts.2017.09.009","volume":"3","author":"VD Myers","year":"2018","unstructured":"Myers, V. D. et al. The multifunctional protein BAG3: a novel therapeutic target in cardiovascular disease. JACC Basic Transl. Sci. 3, 122\u2013131 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"92_CR19","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.jacc.2018.08.2171","volume":"72","author":"C Vasilescu","year":"2018","unstructured":"Vasilescu, C. et al. Genetic basis of severe childhood-onset cardiomyopathies. J. Am. Coll. Cardiol. 72, 2324\u20132338 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"92_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","volume":"141","author":"F Mazzarotto","year":"2020","unstructured":"Mazzarotto, F. et al. Reevaluating the genetic contribution of monogenic dilated cardiomyopathy. Circulation 141, 387\u2013398 (2020).","journal-title":"Circulation"},{"key":"92_CR21","volume":"1","author":"S Shah","year":"2020","unstructured":"Shah, S. et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat. Commun. 1, 63 (2020).","journal-title":"Nat. Commun."},{"key":"92_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","volume":"144","author":"E Jordan","year":"2021","unstructured":"Jordan, E. et al. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation 144, 7\u201319 (2021).","journal-title":"Circulation"},{"key":"92_CR23","doi-asserted-by":"crossref","unstructured":"Jord\u00e0, P. et al. BAG3 genetic cardiomyopathy may overlap fulminant myocarditis clinical findings. Circ. Heart Fail. 15, e008443 (2022).","DOI":"10.1161\/CIRCHEARTFAILURE.121.008443"},{"key":"92_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027373","volume":"23","author":"HQ Qu","year":"2022","unstructured":"Qu, H. Q., Feldman, A. M. & Hakonarson, H. Genetics of BAG3: a paradigm for developing precision therapies for dilated cardiomyopathies. J. Am. Heart Assoc. 23, e027373 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"92_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029938","volume":"24","author":"TG Martin","year":"2023","unstructured":"Martin, T. G. et al. Dysregulated autophagy and sarcomere dysfunction in patients with heart failure with co-occurrence of P63A and P380S BAG3 variants. J. Am. Heart Assoc. 24, e029938 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"92_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00335-023-09978-z","volume":"2","author":"M Koslow","year":"2023","unstructured":"Koslow, M., Mondaca-Ruff, D. & Xu, X. Transcriptome studies of inherited dilated cardiomyopathies. Mamm. Genome 2, 312\u2013322 (2023).","journal-title":"Mamm. Genome"},{"key":"92_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamacardio.2024.3547","volume":"9","author":"J Park","year":"2024","unstructured":"Park, J. et al. Bidirectional risk modulator and modifier variant of dilated and hypertrophic cardiomyopathy in BAG3. JAMA Cardiol. 9, 1124\u20131133 (2024).","journal-title":"JAMA Cardiol."},{"key":"92_CR28","doi-asserted-by":"publisher","first-page":"102648","DOI":"10.1016\/j.jaccas.2024.102648","volume":"22","author":"YB Patel","year":"2024","unstructured":"Patel, Y. B., David, W., Terzic, M., Mehla, A. & Swadia, T. V. BAG-3 mutation dilated cardiomyopathy with left ventricular noncompaction in young healthy adult. JACC Case Rep. 22, 102648 (2024).","journal-title":"JACC Case Rep."},{"key":"92_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41588-025-02140-2","volume":"57","author":"DSM Lee","year":"2025","unstructured":"Lee, D. S. M. et al. Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum. Nat. Genet. 57, 829\u2013838 (2025).","journal-title":"Nat. Genet."},{"key":"92_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9695","volume":"6","author":"A Rosati","year":"2015","unstructured":"Rosati, A. et al. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Nat. Commun. 6, 8695 (2015).","journal-title":"Nat. Commun."},{"key":"92_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jcb.30172","volume":"123","author":"B Dufrusine","year":"2022","unstructured":"Dufrusine, B. et al. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration. J. Cell Biochem. 123, 65\u201376 (2022).","journal-title":"J. Cell Biochem."},{"key":"92_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jcb.30171","volume":"123","author":"M De Marco","year":"2022","unstructured":"De Marco, M. et al. BAG3 induces \u03b1-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patients. J. Cell Biochem. 123, 91\u2013101 (2022).","journal-title":"J. Cell Biochem."},{"key":"92_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.8","volume":"4","author":"M De Marco","year":"2013","unstructured":"De Marco, M. et al. Detection of soluble BAG3 and anti-BAG3 antibodies in patients with chronic heart failure. Cell Death Dis. 4, e495 (2013).","journal-title":"Cell Death Dis."},{"key":"92_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jchf.2014.05.012","volume":"2","author":"M De Marco","year":"2014","unstructured":"De Marco, M. et al. BAG3 protein in advanced-stage heart failure. JACC Heart Fail. 2, 673\u2013675 (2014).","journal-title":"JACC Heart Fail."},{"key":"92_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cca.2015.02.048","volume":"445","author":"PU Gandhi","year":"2015","unstructured":"Gandhi, P. U. et al. Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure. Clin. Chim. Acta 445, 73\u201378 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"92_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05271-y","volume":"22","author":"A Falco","year":"2024","unstructured":"Falco, A. et al. Presence of BAG3 protein in serum samples from patients affected by psoriasis. J. Transl. Med. 22, 461 (2024).","journal-title":"J. Transl. Med."},{"key":"92_CR37","doi-asserted-by":"publisher","first-page":"116578","DOI":"10.1016\/j.biopha.2024.116578","volume":"174","author":"M De Marco","year":"2024","unstructured":"De Marco, M. et al. Response to antifibrotic therapy and decrease of circulating BAG3 protein levels in systemic sclerosis patients with reduced forced vital capacity. Biomed. Pharmacother. 174, 116578 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"92_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ejhf.2742","volume":"25","author":"R Mohebi","year":"2023","unstructured":"Mohebi, R. et al. Inflammation across universal definition of heart failure stages: the CASABLANCA study. Eur. J. Heart Fail. 25, 152\u2013160 (2023).","journal-title":"Eur. J. Heart Fail."},{"key":"92_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41569-023-00888-w","volume":"20","author":"J Deroissart","year":"2023","unstructured":"Deroissart, J. & Binder, C. J. Mapping the functions of IgM antibodies in atherosclerotic cardiovascular disease. Nat. Rev. Cardiol. 20, 433\u2013434 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"92_CR40","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1161\/ATVBAHA.124.319847","volume":"44","author":"BP Ransegnola","year":"2024","unstructured":"Ransegnola, B. P., Pattarabanjird, T. & McNamara, C. A. Tipping the scale: atheroprotective IgM-producing B cells in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 44, 1906\u20131915 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"92_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15781","volume":"8","author":"SA Newland","year":"2017","unstructured":"Newland, S. A. et al. Type-2 innate lymphoid cells control the development of atherosclerosis in mice. Nat. Commun. 8, 15781 (2017).","journal-title":"Nat. Commun."},{"key":"92_CR42","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacbts.2019.07.002","volume":"4","author":"A Knutsson","year":"2019","unstructured":"Knutsson, A. et al. Associations of interleukin-5 with plaque development and cardiovascular events. JACC Basic Transl. Sci. 4, 891\u2013902 (2019).","journal-title":"JACC Basic Transl. Sci."},{"key":"92_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.939378","volume":"13","author":"M Ikutani","year":"2022","unstructured":"Ikutani, M. & Nakae, S. Heterogeneity of group 2 innate lymphoid cells defines their pleiotropic roles in cancer, obesity, and cardiovascular diseases. Front. Immunol. 13, 939378 (2022).","journal-title":"Front. Immunol."},{"key":"92_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1326440","volume":"14","author":"M Kral","year":"2023","unstructured":"Kral, M., van der Vorst, E. P. C., Surnov, A., Weber, C. & D\u00f6ring, Y. ILC2-mediated immune crosstalk in chronic (vascular) inflammation. Front. Immunol. 14, 1326440 (2023).","journal-title":"Front. Immunol."},{"key":"92_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/ph15080920","volume":"15","author":"PR Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves, P. R., Nascimento, L. D., Gerlach, R. F., Rodrigues, K. E. & Prado, A. F. Matrix metalloproteinase 2 as a pharmacological target in heart failure. Pharmaceuticals 15, 920 (2022).","journal-title":"Pharmaceuticals"},{"key":"92_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.010849","volume":"16","author":"LF Buckley","year":"2023","unstructured":"Buckley, L. F. et al. MMP-2 associates with incident heart failure and atrial fibrillation: the ARIC Study. Circ. Heart Fail. 16, e010849 (2023).","journal-title":"Circ. Heart Fail."},{"key":"92_CR47","doi-asserted-by":"publisher","first-page":"13691","DOI":"10.3390\/ijms252413691","volume":"25","author":"M Wolosowicz","year":"2024","unstructured":"Wolosowicz, M., Prokopiuk, S. & Kaminski, T. W. The complex role of matrix metalloproteinase-2 (MMP-2) in health and disease. Int. J. Mol. Sci. 25, 13691 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"92_CR48","doi-asserted-by":"publisher","first-page":"e70437","DOI":"10.1371\/journal.pone.0070437","volume":"8","author":"KW Seo","year":"2013","unstructured":"Seo, K. W. et al. Mechanical stretch increases MMP-2 production in vascular smooth muscle cells via activation of PDGFR-\u03b2\/Akt signaling pathway. PLoS ONE 8, e70437 (2013).","journal-title":"PLoS ONE"},{"key":"92_CR49","first-page":"1623","volume":"8","author":"M De Marco","year":"2024","unstructured":"De Marco, M. et al. Overexpression of BAG3 (Bcl2-associated athanogene 3) in serum and skin of patients with systemic sclerosis. Clin. Exp. Rheumatol. 8, 1623\u20131628 (2024).","journal-title":"Clin. Exp. Rheumatol."},{"key":"92_CR50","volume":"12","author":"P Freedman","year":"2025","unstructured":"Freedman, P. et al. Extracellular BAG3 is elevated in early diffuse systemic sclerosis. Mil. Med. Res. 12, 37 (2025).","journal-title":"Mil. Med. Res."},{"key":"92_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B. et al. Universal definition and classification of heart failure. J. Card. Fail. 27, 387\u2013413 (2021).","journal-title":"J. Card. Fail."}],"container-title":["npj Cardiovascular Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00092-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00092-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00092-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:03:00Z","timestamp":1761818580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00092-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92"],"URL":"https:\/\/doi.org\/10.1038\/s44325-025-00092-4","relation":{},"ISSN":["2948-2836"],"issn-type":[{"value":"2948-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.D.M., A.R., L.M., C.V., V.D.L. and M.C.T. report equity holdings in Fibrosys, an academic spin-off from the University of Salerno. J.L.J. has received research grants from Abbott Diagnostics, Applied Therapeutics, AstraZeneca, HeartFlow, and Novartis; he has received consulting fees\/honorarium from Abbott, AstraZeneca, Beckman-Coulter, Boehringer-Ingelheim, Bristol-Myers, Intellia, Jana Care, Novartis, Pfizer, Merck, Roche Diagnostics and Siemens; He participates on data safety monitoring boards or endpoint committees for Abbott, Abbvie, Bayer, CVRx, Pfizer, Roche Diagnostics and Takeda and reports equity holdings in Fibrosys, Imbria Pharmaceuticals and Jana Care. The rest of the authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}